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Introduction
Mechanical complications after myocardial infarction (MI) 
have become uncommon since the introduction of primary 
angioplasty.1 They can lead to a rapid clinical deterioration 
and a fatal outcome, with patient’s survival being depen dent 
on their prompt recognition and intervention. We describe a 
case of two rare mechanical complications: a partial papillary 
muscle rupture after MI, followed by an early severe obstructive 
thrombosis of the implanted bioprosthetic valve.
Case report
We report a case of a 70 year-old male, with a history of 
dyslipidaemia and smoking habits, who suffered an inferior 
ST elevation myocardial infarction (STEMI). Given the 
impossibility to achieve a timely percutaneous coronary artery 
intervention, thrombolysis was performed within 4 hours of 
symptoms onset. Advanced atrioventricular block requiring a 
transcutaneous pacemaker occurred soon after, followed by 
cardiorespiratory arrest in ventricular fibrillation, which was 
reversed after one cycle of advanced life support. The patient 
was transported by airplane to a percutaneous coronary 
intervention (PCI)-capable centre. Coronary angiography 
showed a 50-60% stenosis in the proximal segment of 
the right coronary artery, which was treated with a bare 
metal stent. Echocardiography showed a moderate left 
ventricular systolic dysfunction (estimated ejection fraction 
of 35%), with inferior, inferolateral and inferoseptal akinesia 
and moderate mitral regurgitation. On the fifth day, the 
patient was transferred to our centre, after a 10-hour flight. 
On admission to intensive care unit, the patient was in 
cardiogenic shock with inotropes and non-invasive ventilation. 
A bedside transthoracic echocardiography revealed a severe 
mitral valve regurgitation of uncertain mechanism, along 
with moderate left ventricle systolic dysfunction and right 
ventricle systolic compromise. Additional characterisation 
by transoesophageal echocardiography revealed a 9 mm 
disruption of the posteromedial papillary muscle consistent 
with a contained, albeit morphologically imminent, rupture. 
The instability of the sub-valvular apparatus, leading to a broad 
posterior leaflet prolapse, caused severe mitral regurgitation 
with an eccentric jet with Coanda effect, reaching the left 
atria roof (Figure 1). The patient underwent urgent mitral 
valve replacement with a biological prosthetic valve (St. Jude 
#29), with preservation of anterior and posterior leaflets. 
The patient experienced a favourable post-operative recovery 
and was discharged 12 days after surgery with anticoagulant 
therapy for three months, in addition to dual antiplatelet 
therapy. On the fourth month after surgery, the patient 
initiated progressive heart failure symptoms (NYHA class III) 
without any further complaints. Additional transthoracic and 
transoesophageal evaluations were performed, revealing a 
significant restriction of the prosthetic mitral valve leaflets 
mobility due to thrombotic material deposition, leading to 
severe obstruction, with a mean gradient of 19 mmHg and an 
effective orifice area estimated by PISA method of 0.4 cm.2 
Additionally, in continuity with the prosthesis, a large mural 
thrombus was present covering the left atrial posteroseptal 
wall (Figure 2). Urgent surgery, within twenty-four hours 
after diagnosis, was performed involving mitral bioprosthesis 
replacement with another biologic prosthesis with significant 
improvement in clinical status. After an extensive study, no 
evidence was found of atrial fibrillation or thrombotic disorders. 
Pathology examination of the excised prosthetic material 
confirmed prosthetic thrombosis, with no signs of endocarditis.
Discussion
In the current era of early mechanical reperfusion, the 
incidence of papillary muscle rupture (PMR) after MI has 
decreased, being less than 0.5%. Although rare, complete or 
partial PMR is a serious complication which can lead to rapid 
clinical deterioration and death.1,2 A great deal of foresight is 
essential for an early recognition of this condition, especially 
in uncommon scenarios, like the case reported. Moreover, 
the patient was submitted to thrombolytic therapy and 
prolonged air travel in the acute phase of MI, which could 
have contributed to additional ischemia and injury.
Transthoracic echocardiography (TTE) is of critical importance 
in the evaluation of patients in cardiogenic shock after MI, and 
so it is the ini tial imaging modality used. It has a sensitivity of 
65–85% for the diagnosis of PMR.3 However, in some cases 
TTE is insufficient to accurately ascertain the mechanism 
causing mitral regurgitation, so an additional characterization 
with transoesophageal echocardiogram (TEE) becomes crucial 
to establish diagnosis. TEE can offer superior visibility and 
characterization of the posterior structures – such as mitral 
valve apparatus – with a diagnostic yield between 95% and 
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Figure 1 – Transoesophageal echocardiogram two-chamber view showing a 9 mm disruption of the posteromedial papillary muscle (pointed with an arrow) consistent 
with a contained, but morphologically imminent rupture, leading to a broad posterior leaflet prolapse and a severe mitral regurgitation with an eccentric jet. LA: Left Atria; 
LV: Left Ventricle.
Figure 2 – Transoesophageal echocardiogram long axis view and 3D zoom on face view of the mitral valve presenting a significant thickening of mitral bioprosthetic 
cusps due to thrombotic material deposition, leading to severe obstruction of the prosthetic valve and a large mural thrombus covering the left atrial posteroseptal wall 
(pointed with an arrow). BPMV: Bioprosthetic Mitral Valve; LA: Left Atria; LV: Left Ventricle.
100%.4,5 Although partial PMR may be more difficult to identify 
than complete rupture, it should always be closely investigated 
in the setting of a flail/prolapse mitral leaflet.5 In our case, 
only TEE evaluation provided a full characterisation of mitral 
valve structure and an accurate identification of the mitral 
valve apparatus disarray. Due to the adverse hemodynamic 
complications associated with PMR, emergent identification 
and treatment are essential to improve patient outcomes. 
The natural history of post-MI PMR is extremely unfavourable 
under medical treatment alone.6 Partial PMR is also considered 
a surgical emergency as most of the cases will progress to 
complete rupture.7 In our case, the instability of the sub-valvular 
apparatus was notorious with potential imminent complete 
rupture, as can be seen in Figure 1.
Bioprosthetic valves are advantageous over mechanical 
ones due to their comparatively lower incidence of 
thromboembolic events and avoidance of long-term 
anticoagulation. Clinically significant bioprosthetic valve 
thrombosis (BPVT) is considered a rare phenomenon, however 
accumulated evidence suggests that it is an under-recognised 
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complication.8 Its diagnosis remains challenging due to a 
general lack of awareness on this condition. A combination of 
clinical and echocardiographic features is helpful for diagnosis. 
Specific predisposing factors to BPVT include low cardiac 
output, left atrial dilatation, prior history of thromboembolic 
events, atrial fibrillation and hypercoagulability. New-onset 
acute heart failure symptoms, progressive dyspnoea, new 
thromboembolic event and regression of heart failure 
symptoms with anticoagulation therapy should be considered 
as flags for this condition. Some echocardiographic features 
support the diagnosis of BPVT, such as: direct visualisation of 
valve thrombosis, like the reported case; a 50% mean gradient 
increase compared with post-operative evaluation; increased 
cusp thickness (>2 mm), especially on the downstream 
aspect of the BPV; abnormal leaflet mobility; regression of 
BPV abnormalities with anticoagulation, usually within 1–3 
months of its initiation or reduced leaflet motion in a cardiac 
CT scan.8,9 The optimal treatment of BPVT remains a matter 
of debate. The strategy depends on clinical presentation, 
patient’s hemodynamic status, presence of BPV obstruction 
and valve location. Conventional treatment options include 
surgery, fibrinolysis and anticoagulation, but anticoagulation 
coupled with surgery remains the mainstay of treatment.10 
Although independence from long term anticoagulation is 
an advantage of bioprosthetic valve replacement, cases like 
the one we described highlight the importance of considering 
this condition even in patients without significant risk 
factors, who display heart failure symptoms early after valve 
replacement. Post-operatively, patients must be categorised 
according to risk, and perhaps long-term anticoagulation 
should be considered for high risk patients, as well as periodic 
echocardiographic evaluation of biological prosthetic valves. In 
both complications described in this case, echocardiographic 
characterization with 2D/3D images was essential for the 
establishment of a correct diagnosis and for guiding treatment. 
This case illustrates two uncommon cardiac mechanical 
complications, being peculiar their association in the same 
patient. Despite their distinct pathophysiology, both conditions 
represent cardiac emergencies requiring a high index of 
suspicion and an accurate diagnosis. Cardiovascular imaging 
stands as an extremely valuable supporting technique in a 
critical-care setting. The precise recognition of the partial 
papillary muscle rupture (occasionally a missed diagnosis) and 
the early obstructive bioprosthetic valve thrombosis allowed a 
prompt and successfully surgical correction of these conditions, 
with significant impact on patient’s health and recovery.
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